In conclusion, Semaglutide GLP-1 may be a viable treatment option for our patients with a BMI over 40 who have struggled with weight loss through traditional methods
If you concentrate on eating healthy foods, and address the underlying causes of the disease, your quality of life will be enhanced
The results revealed that the incidence of adequate bowel cleaning was similar among the three groups
Researchers are exploring its efficacy and safety in treating various conditions, including growth hormone deficiencies, cachexia (muscle wasting), and potentially even obesity and diabetes
"It makes sense because obesity is a chronic disease and like most of our other chronic diseases, like high blood pressure, we wouldn't imagine stopping high blood pressure medications once blood pressure is at target." Heather White knows the challenges of excess weight and its medical consequences first hand
In the U.K., between 2007 and October 2025, 1,296 yellow card reports of pancreatitis linked to GLP-1 receptor agonists or dual GLP-1/GIP receptor agonists were reported, of which 19 were fatal